메뉴 건너뛰기




Volumn 157, Issue 5, 2012, Pages 543-552

Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL

Author keywords

Brentuximab vedotin; Hodgkin lymphoma; Mini BEAM; Refractory lymphoma; Salvage chemotherapy

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; OFATUMUMAB; PREDNISOLONE; PROCARBAZINE; RITUXIMAB; THALIDOMIDE; VINBLASTINE; VINCRISTINE;

EID: 84860834338     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09096.x     Document Type: Article
Times cited : (11)

References (35)
  • 2
    • 24944446863 scopus 로고    scopus 로고
    • Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens
    • Ardeshna, K.M., Kakouros, N., Qian, W., Powell, M.G., Saini, N., D'Sa, S., Mackinnon, S., Hoskin, P.J., Goldstone, A.H. & Linch, D.C. (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. British Journal of Haematology, 130, 363-372.
    • (2005) British Journal of Haematology , vol.130 , pp. 363-372
    • Ardeshna, K.M.1    Kakouros, N.2    Qian, W.3    Powell, M.G.4    Saini, N.5    D'Sa, S.6    Mackinnon, S.7    Hoskin, P.J.8    Goldstone, A.H.9    Linch, D.C.10
  • 8
    • 80054750428 scopus 로고    scopus 로고
    • R-CHOP14 versus R-CHOP 21: result of a randomized phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma
    • (ASCO Meeting Abstracts)
    • Cunningham, D., Smith, P., Mouncey, P., Qian, W., Jack, S., Pocock, C., Ardeshna, K., Radford, J.A., Davies, A.J., McMillan, A. & Linch, D.C. (2011) R-CHOP14 versus R-CHOP 21: result of a randomized phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma. Journal of Clinical Oncology (ASCO Meeting Abstracts), 29, 8000.
    • (2011) Journal of Clinical Oncology , vol.29 , pp. 8000
    • Cunningham, D.1    Smith, P.2    Mouncey, P.3    Qian, W.4    Jack, S.5    Pocock, C.6    Ardeshna, K.7    Radford, J.A.8    Davies, A.J.9    McMillan, A.10    Linch, D.C.11
  • 12
    • 0024423332 scopus 로고
    • Effectiveness of high-dose chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy
    • Gribben, J.G., Goldstone, A.H., Linch, D.C., Taghipour, G., McMillan, A.K., Souhami, R.L., Earl, H. & Richards, J.D. (1989) Effectiveness of high-dose chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. Journal of Clinical Oncology, 7, 1621-1629.
    • (1989) Journal of Clinical Oncology , vol.7 , pp. 1621-1629
    • Gribben, J.G.1    Goldstone, A.H.2    Linch, D.C.3    Taghipour, G.4    McMillan, A.K.5    Souhami, R.L.6    Earl, H.7    Richards, J.D.8
  • 13
    • 34250223441 scopus 로고    scopus 로고
    • Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma
    • Jabbour, E., Hosing, C., Ayers, G., Nunez, R., Anderlini, P., Pro, B., Younes, A., Hagemeister, F., Kwah, L. & Fayad, L. (2007) Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma. Cancer, 109, 2481-2489.
    • (2007) Cancer , vol.109 , pp. 2481-2489
    • Jabbour, E.1    Hosing, C.2    Ayers, G.3    Nunez, R.4    Anderlini, P.5    Pro, B.6    Younes, A.7    Hagemeister, F.8    Kwah, L.9    Fayad, L.10
  • 14
    • 77954709859 scopus 로고    scopus 로고
    • Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma; survival data from the UKLG LY09 randomized control trial (ISRCTN97144519)
    • Johnson, P.W., Sydes, M.R., Hancock, B.W., Cullen, M., Radford, J.A. & Stenning, S.P. (2010) Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma; survival data from the UKLG LY09 randomized control trial (ISRCTN97144519). Journal of Clinical Oncology, 28, 3352-3359.
    • (2010) Journal of Clinical Oncology , vol.28 , pp. 3352-3359
    • Johnson, P.W.1    Sydes, M.R.2    Hancock, B.W.3    Cullen, M.4    Radford, J.A.5    Stenning, S.P.6
  • 16
    • 33947603127 scopus 로고    scopus 로고
    • Integrating PET and PET/CT into the risk-adapted therapy of lymphoma
    • Kasamon, Y.L., Jones, R.J. & Wahl, R.L. (2007) Integrating PET and PET/CT into the risk-adapted therapy of lymphoma. Journal of Nuclear Medicine, 48(Suppl. 1), 19S-27S.
    • (2007) Journal of Nuclear Medicine , vol.48 , Issue.SUPPL. 1
    • Kasamon, Y.L.1    Jones, R.J.2    Wahl, R.L.3
  • 17
    • 30744445985 scopus 로고    scopus 로고
    • Similar response rates and earlier progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine etoposide, cytarabine and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
    • Kuruvilla, J., Nagy, T., Pintilie, M., Tsang, R., Keating, A. & Crump, M. (2006) Similar response rates and earlier progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine etoposide, cytarabine and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma. Cancer, 106, 353-360.
    • (2006) Cancer , vol.106 , pp. 353-360
    • Kuruvilla, J.1    Nagy, T.2    Pintilie, M.3    Tsang, R.4    Keating, A.5    Crump, M.6
  • 23
    • 1542359509 scopus 로고    scopus 로고
    • Effectiveness of high dose chemotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease
    • Moskowitz, C.H., Kewalramani, T., Nimer, S.D., Gonzalez, M., Zelenetz, A.D. & Yahalom. (2004) Effectiveness of high dose chemotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease. British Journal of Haematology, 124, 645-652.
    • (2004) British Journal of Haematology , vol.124 , pp. 645-652
    • Moskowitz, C.H.1    Kewalramani, T.2    Nimer, S.D.3    Gonzalez, M.4    Zelenetz, A.D.5    Yahalom6
  • 24
    • 78649748606 scopus 로고    scopus 로고
    • Pretransplanation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
    • Moskowitz, A., Yahalom, J., Kewalramani, T., Maragulia, J.C., Vanak, J.M., Zelenetz, A.D. & Moskowitz, C.H. (2010) Pretransplanation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood, 116, 4934-4937.
    • (2010) Blood , vol.116 , pp. 4934-4937
    • Moskowitz, A.1    Yahalom, J.2    Kewalramani, T.3    Maragulia, J.C.4    Vanak, J.M.5    Zelenetz, A.D.6    Moskowitz, C.H.7
  • 25
    • 46749090038 scopus 로고    scopus 로고
    • Current role of gemcitabine in the treatment of Hodgkin lymphoma
    • Oki, Y. & Younes, A. (2008) Current role of gemcitabine in the treatment of Hodgkin lymphoma. Leukaemia and Lymphoma, 49, 883-889.
    • (2008) Leukaemia and Lymphoma , vol.49 , pp. 883-889
    • Oki, Y.1    Younes, A.2
  • 28
    • 33644687850 scopus 로고    scopus 로고
    • Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease
    • Seyfarth, B., Josting, A., Dreyling, M. & Schmitz, N. (2006) Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease. British Journal of Haematology, 133, 3-18.
    • (2006) British Journal of Haematology , vol.133 , pp. 3-18
    • Seyfarth, B.1    Josting, A.2    Dreyling, M.3    Schmitz, N.4
  • 29
    • 0037630376 scopus 로고    scopus 로고
    • Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation
    • Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Balzarini, J., Wolf-Peeters, C.D., Mortelmans, L. & Verhoef, G. (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood, 102, 53-59.
    • (2003) Blood , vol.102 , pp. 53-59
    • Spaepen, K.1    Stroobants, S.2    Dupont, P.3    Vandenberghe, P.4    Maertens, J.5    Bormans, G.6    Balzarini, J.7    Wolf-Peeters, C.D.8    Mortelmans, L.9    Verhoef, G.10
  • 30
    • 84860842155 scopus 로고    scopus 로고
    • FDA approves brentuximab vedotin in two lymphoma indications
    • Stenger, M. (2011) FDA approves brentuximab vedotin in two lymphoma indications. ASCO Post, 2.
    • (2011) ASCO Post , vol.2
    • Stenger, M.1
  • 34
    • 84876203658 scopus 로고    scopus 로고
    • Response-adjusted transplantation in primary resistant and relapsed Hodgkin lymphoma
    • (ASH annual meeting abstracts)
    • Thomson, K., Kayani, I., Ardeshna, K.M., Morris, E., Hough, R., Goldstone, A.H., Linch, D.C. & Peggs, K.S. (2011) Response-adjusted transplantation in primary resistant and relapsed Hodgkin lymphoma. Blood (ASH annual meeting abstracts), 118, 336.
    • (2011) Blood , vol.118 , pp. 336
    • Thomson, K.1    Kayani, I.2    Ardeshna, K.M.3    Morris, E.4    Hough, R.5    Goldstone, A.H.6    Linch, D.C.7    Peggs, K.S.8
  • 35
    • 0031024323 scopus 로고    scopus 로고
    • Progenitor-cell mobilization after low dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
    • Watts, M.J., Sullivan, A.M., Jamieson, E., Pearce, R., Fielding, A., Devereux, S., Goldstone, A.H. & Linch, D.C. (1997) Progenitor-cell mobilization after low dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. Journal of Clinical Oncology, 15, 535-546.
    • (1997) Journal of Clinical Oncology , vol.15 , pp. 535-546
    • Watts, M.J.1    Sullivan, A.M.2    Jamieson, E.3    Pearce, R.4    Fielding, A.5    Devereux, S.6    Goldstone, A.H.7    Linch, D.C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.